Clinical trials
Hypothyroidism trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2011 | 1 |
| 2013 | 3 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 10 |
| Completed | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shandong Provincial Hospital | 2 |
| Beijing Chao Yang Hospital | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 1 |
| Fudan University | 1 |
| Jiangxi Provincial Cancer Hospital | 1 |
| Merck KGaA, Darmstadt, Germany | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Sun Yat-sen University | 1 |
| The Second Affiliated Hospital of Jiaxing University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypothyroidism | 12 |
| Endocrine System Diseases | 2 |
| Thyroid Diseases | 2 |
| Atherosclerosis | 1 |
| Atrial Fibrillation | 1 |
| Breast Neoplasms | 1 |
| COVID-19 | 1 |
| Exophthalmos | 1 |
| Hyperthyroidism | 1 |
| Myocardial Infarction | 1 |
Trials
Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.